Development and Validation of a Predictive Model for 6 Month Rebleeding in Cirrhotic Patients with Esophagogastric Variceal Bleeding
This study developed and validated a high-performing XGBoost predictive model, utilizing five core clinical predictors identified via LASSO regression, to accurately assess the 6-month rebleeding risk in cirrhotic patients with esophagogastric variceal bleeding.